Insulin icodec - Novo Nordisk
Alternative Names: 148-0287-A; AWIQLI; Insulin 287; LAI-287; Long-acting basal insulin analogue-287 - Novo-Nordisk; Long-acting-insulin-287 - Novo-Nordisk; NN-1436; NN-1956; NNC-0148-0000-0287; NNC0148-0287 C; OI 287GTLatest Information Update: 06 Jun 2025
At a glance
- Originator Novo Nordisk
- Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Insulin receptor agonists; Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Type 1 diabetes mellitus; Type 2 diabetes mellitus